` CNBI (China BCT Pharmacy Group Inc) vs S&P 500 Comparison - Alpha Spread

C
CNBI
vs
S&P 500

Over the past 12 months, CNBI has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +19% growth.

Stocks Performance
CNBI vs S&P 500

Loading
CNBI
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CNBI vs S&P 500

Loading
CNBI
S&P 500
Difference
www.alphaspread.com

Performance By Year
CNBI vs S&P 500

Loading
CNBI
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
China BCT Pharmacy Group Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

China BCT Pharmacy Group Inc
Glance View

Market Cap
3.8k USD
Industry
Health Care

China BCT Pharmacy Group, Inc. engages in the distribution, retail and manufacture of pharmaceuticals. The company is headquartered in Liuzhou, Guangxi and currently employs 1,677 full-time employees. The company went IPO on 2010-03-03. The firm operates in three segments: pharmaceutical distribution, retail pharmacy and manufacturing. The firm conducts its wholesale business through Liuzhou BCT. BCT Retail operates a regional retail network in Guangxi province. Hefeng Pharmaceutical has a manufacturing facility located on approximately 40,000 square meters of land.

CNBI Intrinsic Value
Not Available
C
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett